Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/22/2013US8563743 Benzofuranone compound and pharmaceutical composition containing same
10/22/2013US8563742 Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
10/22/2013US8563741 CDK inhibitors containing a zinc binding moiety
10/22/2013US8563732 Oxyimino compounds and the use thereof
10/22/2013US8563730 Pyrazole and fused pyrazole glucokinase activators
10/22/2013US8563729 Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators
10/22/2013US8563717 Adenine derivatives
10/22/2013US8563715 Pyrimidine derivative having cell protecting effect and uses thereof
10/22/2013US8563618 Skin external preparation having excellent stability
10/22/2013US8563617 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
10/22/2013US8563616 Desensitizing drug product
10/22/2013US8563615 Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders
10/22/2013US8563614 Use of treprostinil to treat neuropathic diabetic foot ulcers
10/22/2013US8563613 Diclofenac topical formulation
10/22/2013US8563612 Antimicrobial agent comprising a cysteine component covalently bound to a substrate in particular by binding through an S-S bridge via a spacer molecule
10/22/2013US8563611 Methods and compositions for promoting the respiratory development of an infant
10/22/2013US8563610 Polyunsaturated fatty acids interactions and oxidative stress disorders
10/22/2013US8563609 Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline
10/22/2013US8563608 Methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
10/22/2013US8563607 Polyphenol proteasome inhibitors, synthesis, and methods of use
10/22/2013US8563606 Solid forms of selective androgen receptor modulators
10/22/2013US8563605 Therapeutic agent for male sterility
10/22/2013US8563604 Silicone gel-based compositions for wound healing and scar reduction
10/22/2013US8563603 Polycyclic compounds and methods related thereto
10/22/2013US8563602 Method of improving animal tissue quality by supplementing the animal diet with oleic acid and selected tocols
10/22/2013US8563601 Method of managing broncho-constrictive condition
10/22/2013US8563599 Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof
10/22/2013US8563598 Beta-lactones as antibacterial agents
10/22/2013US8563597 Fused tricyclic ether carbamates and their use
10/22/2013US8563596 Enantiomerically pure compounds for the treatment of proliferative disorders
10/22/2013US8563595 Treatment of cancer with complex organic-inorganic pigment compositions
10/22/2013US8563594 S1P3 receptor inhibitors for treating pain
10/22/2013US8563593 Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
10/22/2013US8563592 Bladder cancer treatment and methods
10/22/2013US8563591 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
10/22/2013US8563590 Compounds, compositions and methods for the treatment of islet amyloid polypeptide (IAPP) accumulation in diabetes
10/22/2013US8563589 Methods of treating neuropathic pain with benzimidazole derivative agonists of PPARgamma
10/22/2013US8563588 Imidazolone derivatives, method for the preparation thereof and biological applications
10/22/2013US8563587 Methods and compositions for treating fish diseases
10/22/2013US8563586 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
10/22/2013US8563585 Fullerene therapies for inflammation
10/22/2013US8563583 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
10/22/2013US8563582 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/22/2013US8563581 Nitroxides for use in treating predisposed or at risk patients
10/22/2013US8563580 Flavivirus inhibitors and methods for their use
10/22/2013US8563579 α-7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
10/22/2013US8563578 Antitumor properties of NO modified protease inhibitors
10/22/2013US8563577 Alkaloid aminoester derivatives and medicinal composition thereof
10/22/2013US8563576 Tri-cyclic pyrazolopyridine kinase inhibitors
10/22/2013US8563575 Fused heterocyclic compounds
10/22/2013US8563574 Parenteral formulation of clopidogrel
10/22/2013US8563573 Azaindole derivatives as CFTR modulators
10/22/2013US8563572 Quaternary opioid carboxamides
10/22/2013US8563571 Crystalline forms of oxymorphone hydrochloride
10/22/2013US8563570 Lactam compounds and their use as pharmaceuticals
10/22/2013US8563569 Compositions and methods for inhibition of the JAK pathway
10/22/2013US8563568 Besylate salt of a BTK inhibitor
10/22/2013US8563567 Substituted heterocyclic compounds
10/22/2013US8563566 Naphthyridine derivatives as potassium channel modulators
10/22/2013US8563565 Pyrazoloquinoline derivatives
10/22/2013US8563564 Composition for skin external application containing gallocatechin gallate for moisturizing effect on the skin
10/22/2013US8563563 Inhibitors of bruton's tyrosine kinase
10/22/2013US8563562 Compounds having antiviral properties
10/22/2013US8563561 3-(3-pyrimidine-2-yl-benzyl)-[1,2,4] triazolo[4,3-b]pyrimidine derivatives
10/22/2013US8563560 Preparation of bicyclic guanidine salts in an aqueous media
10/22/2013US8563556 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one lactic acid salts
10/22/2013US8563555 Pharmaceutical compositions containing a crystalline form of posaconazole
10/22/2013US8563554 Deuterated pyrazinoisoquinoline compounds
10/22/2013US8563553 Compounds and compositions as protein kinase inhibitors
10/22/2013US8563552 Whitening agent and skin external preparation
10/22/2013US8563551 Method for preventing or treating a disease related to the glucocorticoid receptor
10/22/2013US8563550 Imidazolothiadiazoles for use as protein kinase inhibitors
10/22/2013US8563549 Pyrimidine derivatives used as PI-3 kinase inhibitors
10/22/2013US8563548 Methylene furanone derivatives and use of said derivatives as a photoprotecting or antioxidant or depigmentation agent in cosmetic or dermatological compositions
10/22/2013US8563547 (6,7-dihydro-2-nitro-5H-imidazol[2,1-b][1,3]oxazin-6-yl) amide compounds, preparation methods and uses thereof
10/22/2013US8563545 Compound useful for the treatment of degenerative and inflammatory diseases
10/22/2013US8563544 2,5-disubstituted arylsulfonamide CCR3 antagonists
10/22/2013US8563543 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
10/22/2013US8563542 Pyrimidine derivatives as protein kinase inhibitors
10/22/2013US8563541 Azepine inhibitors of Janus kinases
10/22/2013US8563540 Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use
10/22/2013US8563539 Aminopyrimidine kinase inhibitors
10/22/2013US8563538 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/22/2013US8563537 Camptothecin derivatives as chemoradiosensitizing agents
10/22/2013US8563536 Compounds having CRTH2 antagonist activity
10/22/2013US8563535 Combination composition comprising benzoyl peroxide and adapalene
10/22/2013US8563534 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
10/22/2013US8563533 Soft protease inhibitors and pro-soft forms thereof
10/22/2013US8563532 Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained
10/22/2013US8563531 Methods of using beta glucan as a radioprotective agent
10/22/2013US8563530 Purine nucleoside phosphoramidate
10/22/2013US8563526 Triazole derivatives, their preparation and their application in therapeutics
10/22/2013US8563524 Compositions comprising avermectin/azelaic acid compounds useful for treating e.g., rosacea
10/22/2013US8563523 Synthetic lipid A derivative
10/22/2013US8563522 Method of maintaining and/or attenuating a decline in quality of life
10/22/2013US8563518 Cyclosporin compositions
10/22/2013US8563501 Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues
10/22/2013US8563472 Synergistic fungicidal and algicidal compositions including 2-hydroxyphenylaldehyde and 2-hydroxyphenylketone heterocycloyhydrazones and copper
10/22/2013US8563470 Anthranilic diamide and cyclodextrin compositions for propagule coating
10/22/2013US8563469 Acrylate/methacrylate-based random copolymer/anthranilic diamide compositions for propagule coating
1 ... 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 ... 7860